Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

New treatments for male hypogonadism are effective and should be personalized.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

Mutations in the DSG4 gene can cause a rare hair disorder similar to monilethrix.

Lasers and light sources can effectively remove hair, work best on fair skin with dark hair, and usually need multiple treatments.

AGA can occur in children with family history; early diagnosis and treatment important.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Human hair follicles can regenerate after removal, but with low success rate.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

New genes and pathways are important for testosterone production and male sexual development.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Hair analysis can detect drug use but requires careful interpretation due to its complexity.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.